← Back to Search

tVNS group for Aging

N/A
Recruiting
Led By John Williamson, PhD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 2 weeks
Awards & highlights

Study Summary

This trial will test whether tVNS can improve cognitive performance when paired with cognitive training in healthy older adults.

Who is the study for?
This trial is for healthy older adults who can commit to the study's requirements. It's not suitable for those with MRI contraindications like pregnancy or metal implants, hearing or vision deficits that affect assessments, physical impairments, traumatic brain injury, dementia signs, major psychiatric illnesses, or unstable chronic conditions.Check my eligibility
What is being tested?
The trial tests if combining cognitive training with transcutaneous vagal nerve stimulation (tVNS), a non-invasive neurostimulation method that may boost neuroplasticity and cognitive performance, can improve brain health and delay aging-related cognitive decline.See study design
What are the potential side effects?
While the document doesn't specify side effects of tVNS and cognitive training in this context, generally tVNS might cause mild skin irritation at the site of stimulation or temporary changes in heart rate.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 2 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in working memory and processing speed contributors

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: tVNS groupActive Control2 Interventions
Participants will undergo cognitive training with tVNS
Group II: Sham groupPlacebo Group1 Intervention
Participants will undergo cognitive training with earlobe sham

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,341 Previous Clinical Trials
715,606 Total Patients Enrolled
28 Trials studying Aging
3,362 Patients Enrolled for Aging
McKnight Brain Research FoundationUNKNOWN
2 Previous Clinical Trials
185 Total Patients Enrolled
1 Trials studying Aging
135 Patients Enrolled for Aging
University of ArizonaOTHER
514 Previous Clinical Trials
148,554 Total Patients Enrolled
5 Trials studying Aging
848 Patients Enrolled for Aging

Media Library

Cognitive Training Clinical Trial Eligibility Overview. Trial Name: NCT04276805 — N/A
Aging Research Study Groups: Sham group, tVNS group
Aging Clinical Trial 2023: Cognitive Training Highlights & Side Effects. Trial Name: NCT04276805 — N/A
Cognitive Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT04276805 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants aged over 20 eligible to join this investigation?

"Participants of this trial must be aged between 65 and 90."

Answered by AI

Is the opportunity for participation in this trial still available to participants?

"Affirmative. According to clinicaltrials.gov, this ongoing trial was first published on the 17th of November 2020 and is currently recruiting 40 patients between two locations. The entry has been modified as recently as June 15th 2022."

Answered by AI

Who is qualified to be part of this clinical investigation?

"This study is looking for 40 elderly adults, aged between 65 and 90 years old."

Answered by AI

How many participants have enrolled in this experiment?

"Indeed, the information hosted on clinicaltrials.gov confirms that this medical trial is presently enlisting patients. It was initially announced on November 17th 2020 and its most recent update occurred on June 15th 2022. 40 volunteers must be recruited from 2 separate sites to meet their target enrolment goal."

Answered by AI
~4 spots leftby Oct 2024